10 employees
ImmuneWorks develops immune tolerance treatments for patients with serious autoimmune diseases in the lung.
2006
$300K
from 1 investors over 1 rounds
ImmuneWorks, Inc. raised $300K on October 30, 2007
Investors: BioCrossroads